Search research articles
Contact Us
Filters
Showing results (21-30 of 129) with videos related to
Page
of 13
Sort By:
Sensors (Basel, Switzerland)
|
November 13, 2025
Advanced Signal Analysis Model for Internal Defect Mapping in Bridge Decks Using Impact-Echo Field Testing
Avishkar Lamsal, Biggyan Lamsal, Bum-Jun Kim, et al.
International Journal of Molecular Sciences
|
March 14, 2026
Comparison of the Efficacy of 35 Anticancer Drugs According to Genomic Profiling and Biological Characteristics of 14 Gastric Cancer Cell Lines
Sung-Hwa Sohn, Hee Jung Sul, Bum Jun Kim, et al.
Oncotarget
|
October 27, 2017
The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
Hyun Joo Jang, Bum Jun Kim, Jung Han Kim, et al.
Oncotarget
|
January 20, 2017
Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review
Bum Jun Kim, Jung Han Kim, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology
|
August 7, 2017
Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review
Jung Han Kim, Bum Jun Kim, Hyun Joo Jang, et al.
Oncotarget
|
December 13, 2017
Survival benefit of anti-angiogenic agents in patients with previously treated advanced gastric or gastroesophageal junction cancer: a meta-analysis
Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, et al.
Oncotarget
|
December 13, 2017
The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis
Bum Jun Kim, Jung Han Kim, Hyun Joo Jang, et al.
The Korean Journal of Internal Medicine
|
January 17, 2018
Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis
Hong Deok Kim, Bum Jun Kim, Hyeong Su Kim, et al.
International Journal of Molecular Sciences
|
February 10, 2024
Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the <i>MET</i> Gene: Doublet Treatment versus Single Agent Treatment
Sung-Hwa Sohn, Hee Jung Sul, Bum Jun Kim, et al.
Journal of Cancer
|
October 5, 2016
Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers
Jung Hoon Kim, Bum Jun Kim, Hyeong Su Kim, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 129) with videos related to
Sort By:
Page
of 13
Sensors (Basel, Switzerland)
|
November 13, 2025
Advanced Signal Analysis Model for Internal Defect Mapping in Bridge Decks Using Impact-Echo Field Testing
Avishkar Lamsal, Biggyan Lamsal, Bum-Jun Kim, et al.
International Journal of Molecular Sciences
|
March 14, 2026
Comparison of the Efficacy of 35 Anticancer Drugs According to Genomic Profiling and Biological Characteristics of 14 Gastric Cancer Cell Lines
Sung-Hwa Sohn, Hee Jung Sul, Bum Jun Kim, et al.
Oncotarget
|
October 27, 2017
The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
Hyun Joo Jang, Bum Jun Kim, Jung Han Kim, et al.
Oncotarget
|
January 20, 2017
Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review
Bum Jun Kim, Jung Han Kim, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology
|
August 7, 2017
Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review
Jung Han Kim, Bum Jun Kim, Hyun Joo Jang, et al.
Oncotarget
|
December 13, 2017
Survival benefit of anti-angiogenic agents in patients with previously treated advanced gastric or gastroesophageal junction cancer: a meta-analysis
Jung Han Kim, Hyeong Su Kim, Bum Jun Kim, et al.
Oncotarget
|
December 13, 2017
The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis
Bum Jun Kim, Jung Han Kim, Hyun Joo Jang, et al.
The Korean Journal of Internal Medicine
|
January 17, 2018
Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis
Hong Deok Kim, Bum Jun Kim, Hyeong Su Kim, et al.
International Journal of Molecular Sciences
|
February 10, 2024
Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the <i>MET</i> Gene: Doublet Treatment versus Single Agent Treatment
Sung-Hwa Sohn, Hee Jung Sul, Bum Jun Kim, et al.
Journal of Cancer
|
October 5, 2016
Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers
Jung Hoon Kim, Bum Jun Kim, Hyeong Su Kim, et al.
Page
of 13